Programming Biology: How Basecamp Research is Using AI to Transform Medicine – Part 2

Brands Transforming Our World

Can AI help cure disease?

Part two of our conversation with Glen Gowers and Oliver Vince, co-founders of the UK’s most ambitious biotechnology companies, Basecamp Research, is now live.

If you enjoyed episode one, this next chapter goes even deeper into what AI could mean for the future of medicine, why Basecamp believes personalised healthcare is within reach, and what it takes to build a globally ambitious technology company from the UK.

In this episode we cover:

• Why AI could help transform the treatment of cancer, genetic diseases and infectious diseases
• How partnerships with NVIDIA and Anthropic are helping Basecamp scale its biological AI models
• Why communicating bold scientific ambitions requires evidence as much as vision
• The leadership lessons Glen and Oliver have learned while building Basecamp Research
• Why they believe the UK can produce the next generation of globally significant AI companies

Listen on Spotify, Apple Podcast, and wherever you get your podcasts.

If you haven’t already, we recommend listening to part one first to hear the extraordinary story behind the company’s founding before diving into this second chapter.

Each month, Giles Fraser and Rory Cellan-Jones quiz a different tech industry leader. We hear their personal stories, what it takes to run the world’s most innovative companies, and how these brands are transforming our world.